Search
Close this search box.

BIO reverses stance on Biosecure Act, pushes WuXi AppTec out

ARTICLE | Politics, Policy & Law

Trade group parting ways with China CDMO, plans to work with Biosecure sponsors to avoid supply chain disruptions 

By Steve Usdin, Washington Editor

March 13, 2024 9:38 PM UTC

Updated on Mar 13, 2024 at 10:57 PM UTC

Editor’s note: This article has been updated to include comments from WuXi AppTec

BIO has reversed its position on anti-China biotech legislation, withdrawing its opposition to the Biosecure Act, committing to work with its sponsors to try to prevent supply chain disruptions, and pushing WuXi AppTec out of the trade association.

The moves come after the trade association was attacked by a prominent member of Congress who accused it of lobbying on behalf of the U.S.’s adversaries, and after CEOs of small and large biotech companies expressed concern that losing access to Chinese contract biologics manufacturers would disrupt ongoing and future drug development activities…